Patent ID: 7357933

Claim:
A method for treating Parkinson's disease comprising administering to a mammal in need thereof an effective amount of sporoderm-broken germination activated Ganoderma lucidum spores (GASP); wherein said sporoderm-broken GASP are produced by soaking Ganoderma lucidum spores in a solution which is selected from the group consisting of water, saline, and a nutritional solution to cause to produce germinated Ganoderma lucidum spores; placing said germinated Ganoderma lucidum spores in a culture box to activate said germinated spores at relative humidity of 65-98% and temperature of 18-48° C. to produce germination-activated Ganoderma lucidum spores so as to enhance production of bioactive substances in said germination activated Ganoderma luidum spores; and treating said germination activated Ganoderma luidum spores with an enzyme with cell wall dissolving property and/or a mechanical means to produce said sporoderm-broken GASP.